Alison Kennedy
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Clinical significance of preleukemic somatic GATA1 mutations in children with Down syndrome.
Journal: Blood
Published: March 18, 2025
Risk Stratification in Older Intensively Treated Patients With AML.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 04, 2024
Selective advantage of mutant stem cells in human clonal hematopoiesis is associated with attenuated response to inflammation and aging.
Journal: Cell stem cell
Published: June 25, 2023
Fractionated vs single-dose gemtuzumab ozogamicin with determinants of benefit in older patients with AML: the UK NCRI AML18 trial.
Journal: Blood
Published: March 29, 2023
Dissecting the early steps of MLL induced leukaemogenic transformation using a mouse model of AML.
Journal: Nature communications
Published: December 12, 2018
Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib.
Journal: Nature medicine
Published: November 05, 2017
Outcome of Azacitidine Therapy in Acute Myeloid Leukemia Is not Improved by Concurrent Vorinostat Therapy but Is Predicted by a Diagnostic Molecular Signature.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 22, 2017
Mutational analysis of disease relapse in patients allografted for acute myeloid leukemia.
Journal: Blood advances
Published: August 23, 2016
Genetically distinct leukemic stem cells in human CD34- acute myeloid leukemia are arrested at a hemopoietic precursor-like stage.
Journal: The Journal of experimental medicine
Published: November 11, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026